Back

Advantage of novel oral anticoagulants compared to vitamin-K antagonist in atrial fibrillation. Data from real world.

27 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Atrial fibrillation - Stroke prevention 2 Oral Anticoagulation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Gabor Antal Simonyi

St Imre University Teaching Hospital, Budapest (Hungary)

10 More presentations in this session

Presentation thumbnail
Associate Professor B. Hudzik (Zabrze, PL)
Abstract Slides
Presentation thumbnail
Professor R. De Caterina (Pisa, IT)
Abstract Slides
Presentation thumbnail
Ms L. Pracht (Munich, DE)
Abstract
Presentation thumbnail
Doctor O. Rutherford (Sarpsborg, NO)
Abstract Slides
Presentation thumbnail
Doctor J. Yu (Koblenz, DE)
Abstract

Access the full session

Session thumbnail
Poster Session 5 - Atrial fibrillation - Stroke prevention 2

The Event

Event poster

ESC Congress 2018

27 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Session
Oral anticoagulation in subclinical atrial fibrillation
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources